Psychoeducation Versus Cognitive-Behavioral Therapy in Bipolar Disorder
Study Details
Study Description
Brief Summary
To examine the impact of cognitive-behavioural therapy on both the episodic and functional outcome of bipolar disorder, in combination with pharmacotherapy.
Primary Hypothesis is twofold:
-
Cognitive Behavioural Therapy will reduce the total symptom burden, as measured both by percentage of time spent ill (both syndromic and subsyndromal) and number of episodes, as compared to psychoeducation
-
Cognitive behavioural therapy will reduce social and occupational disability to a greater extent than psychoeducation.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Objective:
To compare the impact of cognitive -behavioral therapy to that of properly structured psycho education on the 'illness burden' and functional outcome of bipolar disorder, in combination with pharmacotherapy.
Interventions:
Subjects will be randomized to either a "control" treatment group cosisting of 6 sessions of group psycho-education (topics include illness recognition, treatment approaches, and monitoring and coping strategies; based on manual by Bauer & McBride, 2002: Life Goals Phase
- or they will be randomized to the "experimental" treatment group: 20 sessions of individual Cognitive Behavioural Therapy for Bipolar Disorder (topics include limited psychoeducation, activity scheduling/behavioural interventions, cognitive techniques, including thought monitoring and challenges to dysfunctional assumptions and other coping techniques; based on manual by Lam et al., 1999: Cognitive Therapy for Bipolar Disorder)
Study Design
Outcome Measures
Primary Outcome Measures
- Longitudinal Interval Follow-up Evaluation (LIFE; Keller et al, 1987). []
- Modified Social Adjustment Scale (SAS II-B; Bauer, 2001) []
- ***Note: all primary outcomes obtained prospectively every 3 months for 18 months []
Secondary Outcome Measures
- Clinician Administered Rating Scale for Mania []
- Hamilton Depression Rating Scale []
- Quality of Life, Enjoyment, and Satisfaction Questionnaire []
- Dysfunctional Attitudes Scale []
- Patient Satisfaction Index []
- Activity and Utilisation Questionnaire []
- Medication Compliance scale []
- Intensity of Somatotherapy Index []
- Coping Inventory for Prodromes of Mania []
- Khavari Alcohol Test. []
- *****Note: all secondary outcomes measured prospectively over 18 months []
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Bipolar I or II
-
Currently either in remission or subsyndromally ill (Hamilton Depression Scale-17<14; Clinician Administered Rating Scale for Mania<12).
-
Age eighteen to sixty.
-
Significant symptoms and/or episodes on at least two occasions in the past three years.
-
Grade six education, able to understand English, and Folstein Minimental Score Exam > 26 to ensure cognitive ability to participate.
-
On mood-stabilizing medication.
Exclusion Criteria:
-
Substance dependence meeting Diagnostic and Statistical Manual of Mental Disorders-IV criteria within the last three months.
-
Acutely highly suicidal or homicidal.
-
Serious other medical condition that would render pharmacotherapy or psychotherapy very difficult such as cancer, severe diabetes, etc.
-
Severe antisocial or borderline personality disorder (personality disorder per se is not exclusionary). Subjects may have other axis I disorders, but bipolar disorder must be the principal disorder requiring treatment.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of British Columbia, Department of Psychiatry | Vancouver | British Columbia | Canada | V6T-2A1 |
2 | St. Joseph's Healthcare, CMHS | Hamilton | Ontario | Canada | L8N-3K7 |
3 | Centre for Addiction and Mental Health | Toronto | Ontario | Canada | M5T-1R8 |
4 | University Health Network | Toronto | Ontario | Canada | M5T-2S8 |
5 | McGill University Health Centre | Montreal | Quebec | Canada | H3G-1A4 |
6 | Douglas Hospital-McGill University | Verdun | Quebec | Canada | H4G-1E2 |
Sponsors and Collaborators
- University Health Network, Toronto
- Stanley Medical Research Institute
Investigators
- Principal Investigator: Sagar V Parikh, M.D., University Health Network, Toronto
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 02-0378-E